<--- Back to Details
First PageDocument Content
Biotechnology / Pharmaceutical industry / Stem cells / Biomanufacturing / Biopharmaceuticals / Food industry / Therapy / Cell therapy / Good manufacturing practice
Date: 2016-04-19 09:57:26
Biotechnology
Pharmaceutical industry
Stem cells
Biomanufacturing
Biopharmaceuticals
Food industry
Therapy
Cell therapy
Good manufacturing practice

Microsoft Word - Summary of UK manufacturing capabilitiesdocx

Add to Reading List

Source URL: ct.catapult.org.uk

Download Document from Source Website

File Size: 2,67 MB

Share Document on Facebook

Similar Documents

3D Printing and Biomechanics 2° Congresso IDBN - Italian Digital Biomanufacturing Network III Thematic Conference European Society of Biomechanichs-ITA Università di Pavia, 5-7 Settembre 2018

DocID: 1u5AH - View Document

June 24, 2016 **DCAT Sharp Sourcing Early Bird Rate Ends Today!** 1. Sandoz Progresses $1 Billion Biomanufacturing Plan for Biosimilars Sandoz, a Novartis division, plans to launch five biosimilars of major

DocID: 1rQsS - View Document

Higher education in China / Education in China / Project 211 / Project 985 / Wuhan University / Kanazawa University / Nanjing No.1 High School

Chinese-Finnish Workshop on Biomanufacturing and Evaluation Techniques(CFWBET-2011) 中芬生物制造与评价技术研讨会 Tianjin, China, April 13~19, 2011

DocID: 1qG30 - View Document

Pharmaceutical industry / Business / Economy / Quality / Value / Biopharmaceuticals / Biotechnology / Validity / Biomanufacturing / Validation / Cleaning validation

| Portfolio Biologicals Bioservices Pharmaceutical

DocID: 1pYsi - View Document

Biotechnology / Pharmaceutical industry / Stem cells / Biomanufacturing / Biopharmaceuticals / Food industry / Therapy / Cell therapy / Good manufacturing practice

Microsoft Word - Summary of UK manufacturing capabilitiesdocx

DocID: 1pJLT - View Document